Back
Sonnet BioTherapeutics Holdings Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Sell
28
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.82
Seasonality Move:
-15.58%
Sell
28
ACAD
ACADIA Pharmaceuticals
Last Price:
14.78
Seasonality Move:
10.16%
Sell
28
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?
- The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.84. The Score for SONN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SONN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.79. The Score for ACAD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SONN Stock Price Chart
What is Sonnet BioTherapeutics Holdings's stock price today?
-
The Sonnet BioTherapeutics Holdings share price today is $1.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight buying pressure.
SONN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 51.02 | Buy |
Chaikin Money Flow: | 21008 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.73 - 1.85) | Buy |
Bollinger Bands (100): | (1.5 - 1.96) | Buy |
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 27.33 | Sell |
Chaikin Money Flow: | 151188 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.52 - 17.28) | Sell |
Bollinger Bands (100): | (17.12 - 27.4) | Sell |
SONN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.8 | Buy |
20-day SMA: | 1.8 | Buy |
50-day SMA: | 1.89 | Sell |
200-day SMA: | 2.46 | Sell |
8-day EMA: | 1.82 | Buy |
20-day EMA: | 1.82 | Buy |
50-day EMA: | 1.83 | Buy |
200-day EMA: | 5.54 | Sell |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.3 | Sell |
20-day SMA: | 16.25 | Sell |
50-day SMA: | 17.56 | Sell |
200-day SMA: | 23.46 | Sell |
8-day EMA: | 15.32 | Sell |
20-day EMA: | 16.12 | Sell |
50-day EMA: | 17.99 | Sell |
200-day EMA: | 21.82 | Sell |
Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.01 per share, and a decrease next year of $0.35 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.53 per share.
Sonnet BioTherapeutics Holdings Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ACADIA Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |